A Phase I Randomized Double-blind Placebo-controlled Study of Single and Multiple Ascending Doses of KBL697 in Healthy Subjects
Latest Information Update: 18 Jun 2025
At a glance
- Drugs KBL 697 (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions
- Sponsors KoBioLabs
Most Recent Events
- 18 Jun 2025 New trial record